Second-degree relative donors for T-replete haploidentical allogeneic stem cell transplantation with high-dose post-transplant cyclophosphamide: toward crossing the major HLA barrier

Garnier A.; Guillaume T.; Peterlin P.; Bene M. C.; Le Bris Y.; Dubruille V.; Mahe B.; Gastinne T.; Touzeau C.; Blin N.; Le Gouill S.; Moreau P.; Chevallier P.

首页> 外文期刊>Bone marrow transplantation >Second-degree relative donors for T-replete haploidentical allogeneic stem cell transplantation with high-dose post-transplant cyclophosphamide: toward crossing the major HLA barrier

【24h】

Second-degree relative donors for T-replete haploidentical allogeneic stem cell transplantation with high-dose post-transplant cyclophosphamide: toward crossing the major HLA barrier

机译：具有高剂量后转基磷胺的T-Replete Haploidentical的二相干细胞移植的二级相对捐献者：跨越主要的HLA屏障

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Bone marrow transplantation》 |2017年第7期|共2页
作者
Garnier A.; Guillaume T.; Peterlin P.; Bene M. C.; Le Bris Y.; Dubruille V.; Mahe B.; Gastinne T.; Touzeau C.; Blin N.; Le Gouill S.; Moreau P.; Chevallier P.;
展开▼
作者单位

Nantes Univ Hosp Dept Hematol Nantes France;

Nantes Univ Hosp Dept Hematol Nantes France;

Nantes Univ Hosp Dept Hematol Nantes France;

Nantes Univ Hosp Dept Hematol Biol Nantes France;

Nantes Univ Hosp Dept Hematol Biol Nantes France;

Nantes Univ Hosp Dept Hematol Nantes France;

Nantes Univ Hosp Dept Hematol Nantes France;

Nantes Univ Hosp Dept Hematol Nantes France;

Nantes Univ Hosp Dept Hematol Nantes France;

Nantes Univ Hosp Dept Hematol Nantes France;

Nantes Univ Hosp Dept Hematol Nantes France;

Nantes Univ Hosp Dept Hematol Nantes France;

Nantes Univ Hosp Dept Hematol Nantes France;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类治疗学;
关键词

相似文献

外文文献
专利

1. Second-degree relative donors for T-replete haploidentical allogeneic stem cell transplantation with high-dose post-transplant cyclophosphamide: toward crossing the major HLA barrier [J] . Garnier A., Guillaume T., Peterlin P., Bone marrow transplantation . 2017,第7期

机译：具有高剂量后转基磷胺的T-Replete Haploidentical的二相干细胞移植的二级相对捐献者：跨越主要的HLA屏障
2. Comparison of Peripheral Blood Stem Cells (PBSC) to Bone Marrow (BM) for T-Replete HLA-Haploidentical Donor Transplantation Using Post-Transplant Cyclophosphamide [J] . Bashey Asad, Zhang MeiJie, McCurdy Shannon R., Blood: The Journal of the American Society of Hematology . 2016,第22期

机译：使用移植后环磷酰胺进行T充足的HLA单倍体供体移植的外周血干细胞（PBSC）与骨髓（BM）的比较
3. Post-Transplant High-Dose Cyclophosphamide Overcomes the Detrimental Effect of a Single-Locus HLA Mismatched in Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplantation [J] . Ferraz Patricia, Pereira Arturo, Suarez-Lledo Maria, Blood: The Journal of the American Society of Hematology . 2018,第NovaelaTreatmentAppr期

机译：移植后的高剂量环磷酰胺克服了单个基因座HLA在无关的供体同种异体造血干细胞移植中失配的不利影响
4. HIGH RISK OF GRAFT FAILURE IN PATIENTS WITH ANTI-HLA ANTIBODIES UNDERGOING HAPLOIDENTICAL STEM CELL TRANSPLANTATION [C] . Stefan O. Ciurea, Marcos de Lima, Pedro Cano, Clinical Histocompatibility Workshop. . 2009

机译：抗HLA抗体患者接枝衰竭的高风险，抗HLA抗体患者进行了寄生干细胞移植
5. Donor selection for patients undergoing allogeneic hematopoietic stem cell transplantation: Assessment of the priorities of Canadian hematopoietic stem cell transplant physicians. [D] . Tay, Jason. 2009

机译：接受同种异体造血干细胞移植的患者的供体选择：加拿大造血干细胞移植医生的优先事项评估。
6. Immune reconstitution after T-cell replete HLA haploidentical hematopoieticstem cell transplantation using high-dose post-transplant cyclophosphamide [O] . Yoshinobu Maeda 2021

机译：T-Cell Repete HLA Haploidentical造血后免疫重建使用高剂量后移植后环磷酰胺移植干细胞移植
7. Comparison of Outcomes of Hematopoietic Cell Transplants from T-Replete Haploidentical Donors Using Post-Transplantation Cyclophosphamide with 10 of 10 HLA-A, -B, -C, -DRB1, and -DQB1 Allele-Matched Unrelated Donors and HLA-Identical Sibling Donors: A Multivariable Analysis Including Disease Risk Index [O] . Bashey Asad, Zhang Xu, Jackson Katelin, 2016

机译：使用移植后的环磷酰胺与10个HLA-A，-B，-C，-DRB1和-DQB1等位基因匹配的无关供体和与HLA相同的同胞供体中的10个进行比较，从T型单倍体供体的造血细胞移植结果比较：包括疾病风险指数在内的多变量分析

Second-degree relative donors for T-replete haploidentical allogeneic stem cell transplantation with high-dose post-transplant cyclophosphamide: toward crossing the major HLA barrier

著录项

相似文献

相关主题

期刊订阅